CORD-19:013ce450f63ae2496b92f987e35b55125a43947f / 19838-19977 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T92","span":{"begin":0,"end":139},"obj":"Sentence"},{"id":"TextSentencer_T92","span":{"begin":0,"end":139},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The rationale for fusion with LT-B was to enhance the immunogenicity of the bivalent vaccine since LT-B also functions as an oral adjuvant."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T92","span":{"begin":0,"end":139},"obj":"Sentence"}],"text":"The rationale for fusion with LT-B was to enhance the immunogenicity of the bivalent vaccine since LT-B also functions as an oral adjuvant."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T73","span":{"begin":35,"end":38},"obj":"Disease"}],"attributes":[{"id":"A73","pred":"mondo_id","subj":"T73","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"}],"text":"The rationale for fusion with LT-B was to enhance the immunogenicity of the bivalent vaccine since LT-B also functions as an oral adjuvant."}